Viewing Study NCT01811732

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-03-26 @ 5:10 PM
Study NCT ID: NCT01811732
Status: COMPLETED
Last Update Posted: 2017-09-27
First Post: 2013-03-08
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Sponsor: Melinta Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Skin and Subcutaneous Tissue Bacterial Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bacterial skin infection View
None skin infection View
None infection View
None skin View
None delafloxacin View
None vancomycin View
None aztreonam View
None MRSA bacteria View
None bacterial infection View
None Anti-Infective Agents View
None Anti-Bacterial Agents View